When Kuete et al. [9] studied the cytotoxicity of IBC in various MDR cancer cell lines, they observed lower sensitivity of ABCB1-overexpressing leukemia cells to IBC than of Dox-vulnerable cells. This evidence concerns the gene ABCB1 and leukemia.